Hyman Charles D Johnson & Johnson Transaction History

Hyman Charles D

$1.79 Billion
Q2 2024

A detailed history of Hyman Charles D transactions in Johnson & Johnson stock. As of the latest transaction made, Hyman Charles D holds 297,667 shares of JNJ stock, worth $46.3 Million. This represents 2.42% of its overall portfolio holdings.

Number of Shares

297,667

Previous 303,032 1.77%

Holding current value

$46.3 Million

Previous $47.9 Million 9.24%

% of portfolio

2.42%

Previous 2.65%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$144.38 - $157.78 $774,598 - $846,489	-5,365 Reduced 1.77%	297,667 $43.5 Million
Q1 2024 May 07, 2024	SELL	$155.22 - $162.74 $233,140 - $244,435	-1,502 Reduced 0.49%	303,032 $47.9 Million
Q4 2023 Feb 06, 2024	SELL	$145.6 - $158.88 $706,160 - $770,568	-4,850 Reduced 1.57%	304,534 $47.7 Million
Q3 2023 Nov 01, 2023	SELL	$155.75 - $174.48 $169,923 - $190,357	-1,091 Reduced 0.35%	309,384 $48.2 Million
Q2 2023 Aug 08, 2023	BUY	$154.35 - $166.11 $281,688 - $303,150	1,825 Added 0.59%	310,475 $51.4 Million
Q1 2023 May 04, 2023	BUY	$151.05 - $180.26 $209,204 - $249,660	1,385 Added 0.45%	308,650 $47.8 Million
Q4 2022 Feb 06, 2023	BUY	$160.2 - $179.79 $42,933 - $48,183	268 Added 0.09%	307,265 $54.3 Million
Q3 2022 Nov 09, 2022	BUY	$161.33 - $179.52 $35,976 - $40,032	223 Added 0.07%	306,997 $50.2 Million
Q2 2022 Aug 02, 2022	BUY	$168.19 - $186.01 $164,826 - $182,289	980 Added 0.32%	306,774 $54.5 Million
Q1 2022 May 09, 2022	BUY	$158.14 - $179.59 $793,072 - $900,643	5,015 Added 1.67%	305,794 $54.2 Million
Q4 2021 Feb 08, 2022	BUY	$155.93 - $173.01 $421,478 - $467,646	2,703 Added 0.91%	300,779 $51.5 Million
Q3 2021 Nov 09, 2021	BUY	$161.5 - $179.47 $504,849 - $561,023	3,126 Added 1.06%	298,076 $48.1 Million
Q2 2021 Aug 05, 2021	SELL	$159.48 - $171.07 $351,334 - $376,867	-2,203 Reduced 0.74%	294,950 $48.6 Million
Q1 2021 Apr 28, 2021	BUY	$153.07 - $170.48 $481,099 - $535,818	3,143 Added 1.07%	297,153 $48.8 Million
Q4 2020 Feb 08, 2021	SELL	$137.11 - $157.38 $246,386 - $282,811	-1,797 Reduced 0.61%	294,010 $46.3 Million
Q3 2020 Oct 26, 2020	BUY	$140.38 - $153.83 $14,459 - $15,844	103 Added 0.03%	295,807 $44 Million
Q2 2020 Aug 06, 2020	BUY	$128.81 - $155.51 $2.47 Million - $2.99 Million	19,195 Added 6.94%	295,704 $41.6 Million
Q1 2020 Apr 30, 2020	SELL	$111.14 - $153.99 $44,789 - $62,057	-403 Reduced 0.15%	276,509 $36.3 Million
Q4 2019 Feb 03, 2020	BUY	$127.5 - $146.44 $34,425 - $39,538	270 Added 0.1%	276,912 $40.4 Million
Q3 2019 Nov 07, 2019	SELL	$126.95 - $142.14 $465,525 - $521,227	-3,667 Reduced 1.31%	276,642 $35.8 Million
Q2 2019 Jul 24, 2019	BUY	$131.15 - $144.24 $103,870 - $114,238	792 Added 0.28%	280,309 $39 Million
Q1 2019 May 13, 2019	BUY	$125.72 - $139.79 $406,704 - $452,220	3,235 Added 1.17%	279,517 $39.1 Million
Q4 2018 Jan 31, 2019	BUY	$122.84 - $147.84 $22,111 - $26,611	180 Added 0.07%	276,282 $35.7 Million
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $299,451 - $351,913	2,463 Added 0.9%	276,102 $38.1 Million
Q2 2018 Aug 06, 2018	BUY	$119.4 - $131.76 $693,952 - $765,789	5,812 Added 2.17%	273,639 $33.2 Million
Q1 2018 May 07, 2018	BUY	$125.1 - $148.14 $349,404 - $413,755	2,793 Added 1.05%	267,827 $34.3 Million
Q4 2017 Feb 06, 2018	SELL	$131.22 - $143.62 $60,754 - $66,496	-463 Reduced 0.17%	265,034 $37 Million
Q3 2017 Nov 13, 2017	SELL	$129.47 - $135.38 $669,359 - $699,914	-5,170 Reduced 1.91%	265,497 $34.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	270,667	270,667 $35.8 Million

Others Institutions Holding JNJ

# of Institutions

4,271

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $407B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hyman Charles D, based on Form 13F filings with the SEC.

News

Stay updated on Hyman Charles D with notifications on news.

Account